279 related articles for article (PubMed ID: 18581137)
21. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
[TBL] [Abstract][Full Text] [Related]
22. Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.
Zavodna K; Krivulcik T; Bujalkova MG; Slamka T; Martinicky D; Ilencikova D; Bartosova Z
BMC Cancer; 2009 Nov; 9():405. PubMed ID: 19930554
[TBL] [Abstract][Full Text] [Related]
23. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
[TBL] [Abstract][Full Text] [Related]
24. Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry.
Stormorken AT; Müller W; Lemkemeyer B; Apold J; Wijnen JT; Fodde R; Möslein G; Møller P
Fam Cancer; 2001; 1(3-4):169-73. PubMed ID: 14574174
[TBL] [Abstract][Full Text] [Related]
25. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
26. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients.
Paraf F; Gilquin M; Longy M; Gilbert B; Gorry P; Petit B; Labrousse F
Histopathology; 2001 Sep; 39(3):250-8. PubMed ID: 11532035
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
[TBL] [Abstract][Full Text] [Related]
28. Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients.
Zahary MN; Kaur G; Abu Hassan MR; Singh H; Naik VR; Ankathil R
World J Gastroenterol; 2012 Feb; 18(8):814-20. PubMed ID: 22371642
[TBL] [Abstract][Full Text] [Related]
29. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
[TBL] [Abstract][Full Text] [Related]
30. Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer.
Krüger S; Plaschke J; Pistorius S; Jeske B; Haas S; Krämer H; Hinterseher I; Bier A; Kreuz FR; Theissig F; Saeger HD; Schackert HK
Hum Mutat; 2002 Jan; 19(1):82. PubMed ID: 11754112
[TBL] [Abstract][Full Text] [Related]
31. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.
Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z
Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
[TBL] [Abstract][Full Text] [Related]
33. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
[TBL] [Abstract][Full Text] [Related]
34. A novel MSH2 mutation in a Chinese family with hereditary non-polyposis colorectal cancer.
Zheng D; Li T; Liu X; Hu W; Chen H; Yang Y
Int J Colorectal Dis; 2007 Aug; 22(8):875-9. PubMed ID: 17333219
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Wang CY; You JF; Hsiung CA; Yeh CC
PLoS One; 2015; 10(6):e0130018. PubMed ID: 26053027
[TBL] [Abstract][Full Text] [Related]
36. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
[TBL] [Abstract][Full Text] [Related]
37. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?
Halvarsson B; Lindblom A; Rambech E; Lagerstedt K; Nilbert M
Virchows Arch; 2004 Feb; 444(2):135-41. PubMed ID: 14652751
[TBL] [Abstract][Full Text] [Related]
39. Detection of DNA mismatch repair proteins in fresh human blood lymphocytes--towards a novel method for hereditary non-polyposis colorectal cancer (Lynch syndrome) screening.
Hassen S; Boman BM; Ali N; Parker M; Somerman C; Ali-Khan Catts ZJ; Ali AA; Fields JZ
J Exp Clin Cancer Res; 2011 Oct; 30(1):100. PubMed ID: 22017758
[TBL] [Abstract][Full Text] [Related]
40. [The analysis for mRNA mutation of MLH1, MSH2 genes and the gene diagnosis for hereditary nonpolyposis colorectal cancer].
Wang CF; Zhou XY; Zhang TM; Sun MH; Xu Y; Shi DR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):32-6. PubMed ID: 16456782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
